Natixis Advisors, L.P. Novartis Ag Transaction History

Natixis Advisors, L.P.

  • $46 Billion
  • Q2 2024

A detailed history of Natixis Advisors, L.P. transactions in Novartis Ag stock. As of the latest transaction made, Natixis Advisors, L.P. holds 912,527 shares of NVS stock, worth $101 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
912,527
Previous 926,655 1.52%
Holding current value
$101 Million
Previous $89.6 Million 8.38%
% of portfolio
0.21%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$92.57 - $107.37 $1.31 Million - $1.52 Million
-14,128 Reduced 1.52%
912,527 $97.1 Million
Q1 2024

Apr 25, 2024
SELL
$95.27 - $108.47 $426,047 - $485,077
-4,472 Reduced 0.48%
926,655 $89.6 Million
Q4 2023

Feb 06, 2024
BUY
$92.27 - $101.54 $301,722 - $332,035
3,270 Added 0.35%
931,127 $94 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $241,845 - $268,396
-2,553 Reduced 0.27%
927,857 $94.5 Million
Q2 2023

Aug 15, 2023
BUY
$92.52 - $104.91 $2.98 Million - $3.38 Million
32,258 Added 3.59%
930,410 $93.9 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $28.3 Million - $32.8 Million
-353,451 Reduced 28.24%
898,152 $82.6 Million
Q4 2022

Jan 27, 2023
SELL
$75.55 - $92.52 $9.83 Million - $12 Million
-130,143 Reduced 9.42%
1,251,603 $114 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $3.12 Million - $3.65 Million
-41,834 Reduced 2.94%
1,381,746 $105 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $25.5 Million - $29.7 Million
-317,146 Reduced 18.22%
1,423,580 $120 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $4.01 Million - $4.53 Million
50,023 Added 2.96%
1,740,726 $153 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $33 Million - $36.5 Million
-414,039 Reduced 19.67%
1,690,703 $148 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $60 Million - $69.8 Million
733,859 Added 53.53%
2,104,742 $172 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $2.79 Million - $3.08 Million
-32,675 Reduced 2.33%
1,370,883 $125 Million
Q1 2021

May 05, 2021
BUY
$83.5 - $98.47 $8.49 Million - $10 Million
101,620 Added 7.81%
1,403,558 $120 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $16.8 Million - $20.4 Million
215,686 Added 19.86%
1,301,938 $123 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $6.28 Million - $6.96 Million
-76,502 Reduced 6.58%
1,086,252 $94.5 Million
Q2 2020

Aug 11, 2020
SELL
$80.93 - $91.1 $4.17 Million - $4.7 Million
-51,554 Reduced 4.25%
1,162,754 $102 Million
Q1 2020

Apr 27, 2020
BUY
$70.67 - $99.01 $7.41 Million - $10.4 Million
104,856 Added 9.45%
1,214,308 $100 Million
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $6.94 Million - $7.85 Million
82,276 Added 8.01%
1,109,452 $105 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $3.32 Million - $3.66 Million
-38,867 Reduced 3.65%
1,027,176 $89.3 Million
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $2.01 Million - $2.47 Million
26,633 Added 2.56%
1,066,043 $97.3 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $2.19 Million - $2.51 Million
29,127 Added 2.88%
1,039,410 $89.5 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $8.86 Million - $9.86 Million
120,270 Added 13.51%
1,010,283 $86.7 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $4.76 Million - $5.5 Million
71,091 Added 8.68%
890,013 $76.7 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $2.61 Million - $2.95 Million
-40,150 Reduced 4.67%
818,922 $0
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $1.17 Million - $1.39 Million
16,571 Added 1.97%
859,072 $69.5 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $3.73 Million - $4 Million
-51,531 Reduced 5.76%
842,501 $70.7 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $66.3 Million - $69.1 Million
894,032
894,032 $76.8 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email